Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-17-061151

Options or other derivatives

  • Director acquired 38,106 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Billings Paul · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-10-04 Grant or award : show line 1 in the form Stock Options +38,106 121,336 D
Loading xslF345X03/a4.xml…